Clomiphene Citrate Combined with Tamoxifen Citrate versus Letrozole for Inducing Ovulation in Patients with Clomiphene Citrate -Resistant Polycystic Ovary Syndrome
Journal of Gynecology & Reproductive Medicine · 2019
DOI: 10.33140/jgrm.03.02.04 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gynecology & Reproductive Medicine, 2019. Die Arbeit nennt 44 Literaturangaben.
Abstract (Originalsprache)
This prospective observational study was conducted on 242 patients with clomiphene citrate (CC) resistant polycystic ovary syndrome (PCOS) who were allocated into two regimens of induction of ovulation, the first group(n=128) received both CC and tamoxifen and the second (n=114) received letrozole. The ovulation rate, endometrial thickness, number of dominant follicles, pregnancy rate, miscarriage rate and live birth rate were found comparable between the two groups. Combined therapy with CC and tamoxifen is beneficial in patients with PCOS who failed to respond to CC alone.
Zitieren
APA
(2019). Clomiphene Citrate Combined with Tamoxifen Citrate versus Letrozole for Inducing Ovulation in Patients with Clomiphene Citrate -Resistant Polycystic Ovary Syndrome. Journal of Gynecology & Reproductive Medicine. https://doi.org/10.33140/jgrm.03.02.04
Vancouver
Clomiphene Citrate Combined with Tamoxifen Citrate versus Letrozole for Inducing Ovulation in Patients with Clomiphene Citrate -Resistant Polycystic Ovary Syndrome. Journal of Gynecology & Reproductive Medicine. 2019. doi:10.33140/jgrm.03.02.04
BibTeX
@article{euvimed2019,
title = {Clomiphene Citrate Combined with Tamoxifen Citrate versus Letrozole for Inducing Ovulation in Patients with Clomiphene Citrate -Resistant Polycystic Ovary Syndrome},
journal = {Journal of Gynecology & Reproductive Medicine},
year = {2019},
doi = {10.33140/jgrm.03.02.04}
}
EUVIMED